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Objectives: To assess time trends of the prevalence of diabetes and mean blood glucose in
Portuguese adults.
Study design: Systematic review.
Methods: The search strategy included Pubmed search and screening of bibliographic ref-
erences of the review articles. Sex-specific linear regression models, with survey year and
participants’ age as independent variables, were used to predict prevalence estimates of
self-reported diabetes and mean fasting glucose.
Results: Twenty-seven eligible studies were identified. Time trends of objectively defined
diabetes could not be quantified due to the heterogeneity of the diagnostic criteria. Be-
tween 1987 and 2009, the prevalence of self-reported diabetes remained approximately
constant in young adults, while it increased in middle-aged and older adults, more than
two-fold among women and three-fold among men. In the same period, mean fasting
glucose increased 7 mg/dL among women and 8 mg/dL among men.
Conclusions: The prevalence of self-reported diabetes and mean fasting glucose increased in
the last two decades, demanding for effective strategies to reverse this tendency and to
manage the increasing number of people with diabetes in the Portuguese population.
ª 2013 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.Introduction
In 2011, 4.6 million people aged 20e79 died from diabetes,
accounting for 8.2% of all-cause mortality in this age range
worldwide.1 People with diabetes have a lower life expectancy
by approximately 12 years.2 Diabetes is also associated with
importantmorbidity, particularly a high absolute risk ofmajor52; fax: þ351 22 551 36 5
artasfpereira@hotmail.c
oyal Society for Public Hcoronary events,3,4 and other disabling consequences like
renal failure and blindness.5,6
In the last decade, cases of glycaemia and diabetes have
increased globally, paralleling the increasing trends in body
mass index7 and population ageing. Some 366 million people
worldwide, corresponding to 8.3% of the adult population,
were estimated to have diabetes in 2011.1 If these trends
continue, it is estimated that by 2030 a total of 552 million3.
om (M. Pereira).
ealth. Published by Elsevier Ltd. All rights reserved.
p u b l i c h e a l t h 1 2 8 ( 2 0 1 4 ) 2 1 4e2 2 1 215people will have diabetes.1 However, there is considerable
variation in time trends across countries and regions, making
generalizations based on subjective assessments of similar-
ities of populations unadvisable.8 Furthermore, understand-
ing the secular development of the epidemiology of diabetes
in different settings is important to define goals for public
health interventions and to predict the morbidity and mor-
tality burden of this condition in the short term.
Themost comprehensive data on the frequency of diabetes
mellitus in Portugal comes from the self-reported data of the
National Health Surveys,9e12 and only recently were three
national surveys carried out using standardized criteria for
diabetes identification.13e15 However, an accurate estimation
of the frequency of diabetes in Portugal requires the best use
of all available resources to obtain detailed information for
different age groups and populations across the widest
possible time span. A systematic review may allow their
identification and description in a standardized format, taking
into account the methodological aspects from each study that
may compromise their internal and external validity, namely
the methods and conditions for glucose measurement and
criteria for definition of diabetes.
We therefore conducted a systematic review to critically
summarize the evidence from studies that provided data on
the distribution of diabetes mellitus and fasting blood glucose
levels in Portuguese adults, in order to analyse time trends.Methods
The present systematic review was conducted as part of a
more comprehensive review that addressed the distribution
of six major cardiovascular risk factors, including hyperten-
sion,16 obesity,17 dyslipidaemia,18 diabetes mellitus, smoking
and physical inactivity, in Portuguese adults. The current
analysis only considers studies with data on the prevalence of
diabetes and/or mean blood glucose. This systematic review
was prepared in strict compliance with PRISMA guidelines for
systematic reviews.
Search strategy
We searched Pubmed from inception to November 2011, to
identify original reports and review articles providing data on
the distribution of the prevalence of diabetes and mean fast-
ing glucose levels in Portuguese populations; the search
expression is provided in the systematic review flowchart
(Fig. 1). The reference lists of the review articles addressing the
distribution of cardiovascular risk factors in Portugal were
screened to identify potentially eligible original reports.
Eligibility criteria and screening of reference lists
Studies were excluded when fulfilling the following criteria,
defined a priori: written in languages other than Portuguese,
English, Spanish, French or Italian; research not involving
humans (e.g. in vitro or animal research); editorials, reviews or
comments; not providing data specifically for Portuguese
subjects; not evaluating adult populations; evaluating sam-
ples of participants not expected to represent the generalpopulation regarding the frequency of the cardiovascular risk
factors under study (e.g. athletes, sedentary elderly); not pre-
senting data on diabetes prevalence or mean glucose levels;
insufficient characterization of the methods (e.g. not speci-
fying the region where the sample was assembled, not
describing the data collection procedures).
The screening of the reference lists was accomplished in
three consecutive steps. In step 1 the exclusion of irrelevant
studies was decided by considering only the title and abstract;
the article was selected for evaluation in step 2 except when
the title or abstract (when available) unequivocally presented
information for exclusion. The full texts of studies selected for
step 2 were then evaluated to decide on their eligibility and
availability of relevant data. The studies selected for step 3
were re-evaluated to determine their adequacy for data
extraction.
Whenmore than one report referred to the same study, we
considered the one providing data for the largest sample or,
when the sample was the same, we used the source pre-
senting the results with more detail, although any of these
reports could be used to collect information on the study
characteristics.
The decisions taken independently by the two reviewers
were compared in all steps and the disagreements were
resolved by consensus or after discussion with a third
researcher.
Data extraction
Two investigators independently collected data from the
studies selected for the systematic review on period of data
collection, recruitment place, geographical coverage of the
study (regional/national), type of population studied (e.g. gen-
eral population, primary health care users, occupational
group, volunteers, university students and pharmacy atten-
dants), type of sampling (probability or non-probability),
sample size and participants’ mean age and sex. When the
period of data collection was not reported, we assumed the
publication year minus the median difference between the
publication year and date of data collection in the articles for
which that information was available (three years). When a
study did not present themean age of the participants in each
age groupwe assumed themid-point of the age interval.When
an age group also included subjects aged below 18 years old
(e.g. age group 17e20 years), we computed the mid-point and
excluded the data if the mid-point year was lower than 17.5
years old. For surveys that reported data by age group but
provided open age intervals at the extremes, we estimated the
midpoint of the highest/lowest categories by adding or sub-
tracting the width of the adjacent class to the lowest/highest
value, respectively, of the extreme classes (e.g. for surveys
reporting data in participants aged<30, 30e39, 40e49, and50
years, we considered the overall range as 20e59 years).
The source of data on the presence of diabetes or fasting
blood glucose (e.g. biochemical tests, self-report or clinical re-
cords), the device for glucose measurement and the fasting
status of participants upon blood withdrawal were also extrac-
ted. Age- and sex-specific estimates of prevalence of diabetes
and blood glucose levels, and the respective criterion for the
definition of the former, were extracted whenever available.
Fig. 1 e Systematic review flowchart.
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p u b l i c h e a l t h 1 2 8 ( 2 0 1 4 ) 2 1 4e2 2 1 217When only graphs were presented we extracted the data by
reading from projections to axes; the articles were excluded
when no accurate reading was possible. From the six largest
studies involving subjects within a wide age range we obtained
age- and sex-specific estimates directly from the authors.
Differences in the data extracted by the two investigators
were discussed until consensus, and involving a third inves-
tigator whenever necessary.
Data analysis
Studies that did not present data stratified by sex were
excluded from all quantitative analyses, as well as one study
addressing specifically type 1 diabetes. Studies relying on non-
fasting blood glucose in the whole or part of the sample were
included to provide estimates of objectively defined diabetes.
However, they were only included if appropriate cut-offs,
different from criteria used for fasting glucose, were used to
define diabetes, but excluded from analyses on mean blood
glucose. We considered self-reported diabetes, previous
diagnosis of diabetes and being on treatment as equivalent
criteria for the definition of self-reported diabetes, under the
assumption that the proportion of treated among aware is
very high.
Data are summarized in figures depicting the age and sex-
specific estimates (whenever available) of the prevalence of
self-reporteddiabetes andmean fasting glucose, as available in
the original reports. Each figure includes lines representing the
sex-specific prediction for prevalence of self-reported diabetes
and mean fasting glucose, as applicable, based on linear
regression models including the mean age of subjects and a
quadratic term,whenevernecessary, as independentvariables.
We fitted multiple linear regression models using the age
and sex-specific estimates of the prevalence of diabetes and
mean fasting glucose as dependent variables, and the
following independent variables: year of data collection and
participants’ mean age. We hypothesized that a quadratic
term of age could improve a model fit given the flattening of
the increase in prevalence with advanced age,19 but since
these terms were not significant, we did not include them in
the final models. We studied the role of an interaction term
between survey year and age, which had a significant effect
only for self-reported diabetes. The equations obtained by
linear regression were used to compute adjusted ecological
estimates of prevalence of self-reported diabetes and mean
fasting glucose in two extreme calendar years for which data
were available (1987 and 2009) at specific ages (30, 50, 70 years)
aiming to represent young, middle-aged and older adults. As
one or more estimates of the outcomes were extracted from
each study, corresponding to different age strata, the confi-
dence intervals were calculated using robust estimates of the
standard errors; this accounts for the dependence among the
observations from the same study.Results
We identified 27 studies eligible for the systematic review
(Fig. 1), published between 1989 and 2011.9e15,20e39 The
detailed description of themethodological characteristics andresults presented in the primary data sources are presented in
a Supplementary file, available online. Ten studies presented
data on the prevalence of objectively defined diabetes, 18
studies on the prevalence of self-reported diabetes and six
studies on mean blood glucose. Twelve studies assessed
representative samples at mainland or national level, of
which four were National Health Surveys. Most studies
considered samples of the general population (16 studies) or
users of primary health care centers (eight studies). Among
the 12 studieswith data on blood glucosemeasurements, used
either for estimation of mean blood glucose or prevalence of
objectively defined diabetes, six did not identify the method
used to measure glucose and in four not all participants were
in fasting conditions when blood glucose was measured.
Seven studies did not present the results stratified by sex and
nine did not stratify the results by age groups (Supplementary
file, available online).
Prevalence of diabetes
Overall, 25 studies presented data on diabetes prevalence,
using 10 different criteria to define diabetes (Supplementary
appendix, available online).
Time trends of objectively defined diabetes could not be
quantified due to the heterogeneity of the criteria for the
diagnosis of diabetes and the scarcity of data pertaining to
each criterion. The prevalence of objectively defined diabetes
ranged from 0.0%, when defined as fasting glucose >110 mg/
dL, among male university students, in 2005, to 40.0%, when
defined as fasting glucose 126 mg/dL and/or previous diag-
nosis and/or being on pharmacological treatment, among
women aged 85e93 years, in 1999e2003. In general, the pro-
portion of subjects with high fasting glucose increased with
age and was higher among men, regardless of the criterion
used to define the outcome.
The prevalence of self-reported diabetes increased with
age, both in women and men (Fig. 2), with no significant dif-
ferences between sexes.
Table 1 depicts the estimated prevalence of self-reported
diabetes in 1987 and 2009, in women and men at 30, 50 and
70 years of age. In this period, the prevalence of self-reported
diabetes remained approximately constant among younger
adults, while it increased in middle-aged and older adults,
more than doubling among women and tripling among men.
In 2009, the prevalence of self-reported diabetes estimated
from the linear regression model was 8.6% and 9.4%,
assuming an average age of 50 years, amongwomen andmen,
respectively (Table 1).
Mean fasting glucose levels
Mean fasting glucose levels increased linearly with age in
women and men (Fig. 2). Mean fasting glucose was 6 mg/dL
[95% confidence interval (95%CI): 2e10] higher among men,
independently of the year of survey and age.
Between 1987 and 2009, mean fasting glucose increased
7 mg/dL (95%CI: 1e12) among women and 8 mg/dL (95%CI:
0e19) amongmen. In 2009, assuming an average age of 50, the
mean glucose levels were 96 mg/dL and 103 mg/dL, among
women and men, respectively (Table 1).
Fig. 2 e Prevalence of self-reported diabetes and mean fasting glucose according to age, in women and men.
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We describe an important increase in the prevalence of self-
reported diabetes in middle-aged and older adults, and in
mean fasting glucose in all adult ages, both in women and
men, in the last two decades, in Portugal.
This review represents themost comprehensive analysis of
estimates of diabetes prevalence and mean blood glucose in
Portugal todate.Our results arebasedonanextensive literature
search that allowed the analysis of long-term trends of both
prevalence of diabetes and mean glucose, taking into account
the methodological variation among studies. Nevertheless,
some limitations need to be acknowledged. The utilization of a
single search engine could decrease the completeness of the
review. However, wemay assume that studies including larger
samples and more thorough methods were more likely to be
published in journalswithwider circulation that are indexed inTable 1 e Prevalence of self-reported diabetes and mean fastin
outcome on participants’ age and year of survey, for specific a
Year W
30 years 50
Prevalence of self-reported diabetesa
% (95% CI)
[11 studies, 65 age- and sex-specific estimates]
1987 2.0 (0.0e4.4) 4.3 (1
2009 1.4 (0.0e3.9) 8.6 (6
Mean fasting glucose
mg/dL (95% CI)
[4 studies, 28 age- and sex-specific estimates]
1987 82 (81e83) 89 (86
2009 89 (82e95) 96 (93
95% CI e 95% confidence interval.
a This model includes an interaction term between the year of survey anMedline. Furthermore, our search strategy included the
screening of the bibliographic references of the review articles
addressing the cardiovascular risk factors, fulfilling a potential
gap of information due to smaller studies published in non-
indexed journals. Since successful publication is not likely to
be determined by the prevalence of a condition, we do not
expect publication bias to be a major issue in this review.
Although the lack of some methodological information in
some reports impaired an appropriate detailed characteriza-
tion of all studies (Supplementary appendix, available online),
those that failed to report on methodological characteristics
deemed essential to interpret the evidence were excluded
from our review.
In the included studies, we observed a considerable het-
erogeneity across the investigations, regarding target pop-
ulations, methods for determining blood glucose and criteria
for defining diabetes. Since some studies referred to selected
population samples, such as primary health care users, weg glucose, predicted from linear regression models of each
ges, in women and men.
omen Men
years 70 years 30 years 50 years 70 years
.2e7.3) 6.6 (2.5e10.6) 1.6 (0.0e3.5) 3.0 (0.6e5.4) 4.4 (0.7e8.1)
.8e10.4) 15.8 (12.7e19.0) 1.8 (0.0e4.1) 9.4 (8.2e10.7) 17.0 (14.7e19.4)
e92) 96 (89e103) 86 (83e88) 95 (88e102) 104 (92e115)
e98) 103 (101e104) 94 (86e103) 103 (95e112) 112 (102e123)
d participants’ age.
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the studies involving samples of the general population (data
not shown). Since the conclusions remained the same,wekept
all studies in our final analysis. We aimed at including studies
that considered samples of the Portuguese population, how-
ever we cannot ensure that migrants were excluded in all
samples since this specific information was hardly ever re-
ported in the original studies, precluding the evaluation of its
potential impact in our results. Additionally, we included the
geographical coverage of the studies as an independent vari-
able in the models, but the results also did not change mean-
ingfully. In statistical analyses on mean blood glucose, we
excluded studies based on randomblood glucose, but no other
quality indicators such as duration of fasting or laboratory
methodswere considered inmodel fitting, since theywere not
systematically reported in the primary studies. Assessment of
trends using population-based studiesmust take these factors
into account, either by restricting to comparable criteria or by
converting scales when possible. The heterogeneity of the
criteria used in primary studies for diagnosis of diabetes pre-
cluded a quantitative analysis of trends in objectively defined
diabetes in our study. However, this partially results from the
continuous debate on and refinement of such criteria, with
diabetes definitions varying among expert committees and
over time.40,41 Changes in criteria for diagnosis over time are
also expected to directly influence the prevalence of self-
reported diabetes. However, the awareness of a diagnosis of
diabetes is intimately related with the need for pharmacologic
treatment and the threshold for initiation of treatment is ex-
pected to depend on the overall risk and not only on blood
glucose levels. Therefore, despite the impossibility of knowing
the specific contribution of the proportion of people with dia-
betes, the proportion of diabetics diagnosed and the aware-
ness of patients diagnosed to the change in the prevalence of
self-reported diabetes over time, this reflects a complex
construct whose relevance goes beyond having blood glucose
above a specified cut-off. The interpretation of the trends in
self-reported diabetes should be made in light of this
perspective. Therefore, although the fluctuations in the diag-
nostic criteria for diabetes could affect the decision to treat at
individual level and the prevalence of diabetes at a population
level, thepublic health implications remain largelyunaffected,
since the cardiovascular risk associated with the serum
glucose level will not depend on using one cut-off vs another.
We have considered being on treatment for diabetes as an
equivalent criterion of self-reported diabetes and previous
diagnosis of diabetes. A sensitivity analysis excluding the only
study thatused this criterionyieldedvirtually the sameresults.
Additionally, wewere not able to ensure that the self-reported
diabetes only included type 2 diabetes. However, since the
analysis regarded adult populations and there is no reason to
believe that the prevalence of type 1 diabetes changed visibly
during this period, we assumed that trends in self-reported
diabetes reflect mainly changes in type 2 diabetes.
Unfortunately, we were not able to quantify trends in
objectively defined diabetes, which precludes definite con-
clusions on the trends of diabetes. However, considering the
trends in mean glucose levels, we may hypothesize a high
burden of this disease in the Portuguese population in the
time span considered. This is further supported by theincrease in the prevalence of self-reported diabetes, which is
likely to reflect both an increase in the awareness of diabetes
and the trend towards higher mean levels of blood glucose.
Current guidelines for the diagnosis of diabetes recommend a
cut-off of fasting plasma glucose of 126 mg/dL. The absolute
level of mean fasting glucose reported in this study was
93.4 mg/dL overall and in older ages approximated a lot to the
diagnostic cut-off. Our results are in accordance with the
trends in Western European populations, reported by a recent
pooled analysis that assessed the variation in mean fasting
glucose since 1980 worldwide.8
Despite men’s higher mean glucose levels at all ages, we
did not find differences in self-reported prevalence of diabetes
by sex. We hypothesize that this pattern results from a lower
use of health care services particularly primary care,42
resulting in a lower proportion of diagnosis and conse-
quently lower awareness among men.14
The time trends in prevalence of diabetes and mean
glucose levels observed in our review are likely to be driven by
the variation in exposure to important determinants of type 2
diabetes, such as physical inactivity, unhealthy diet and
obesity.43e45 In Portugal, there are no robust data on the trends
in physical activity levels. However, data from the National
Health Survey of 1998e1999 showed that 71% of the Portu-
guese adult populationwas sedentary.11 The dietary pattern in
the country markedly changed in the last decades, towards a
more westernized diet.46 The prevalence of overweight
increased 3% and 4%, and the prevalence of obesity increased
7% and 1% among women and men, respectively, between
1995 and 2005, resulting in more than 40% of the Portuguese
adults being overweight and around 20% obese in 2005. Spe-
cifically overweight and obesity markedly increased among
young subjects between 1986 and 2000.17 The apparent
contrast with the constant prevalence of self-reported dia-
betes among young adults in the current study is likely related
with a lower attendance to health care services and a
considerable proportion of undiagnosed subjects at such
young ages cannot be ruled out, since diabetes can remain
asymptomatic for many years.40 The variation in the mean
glucose levels results from the balance between changes in
lifestyles and in the uptake of anti-diabetic medications. The
increase in prevalence of self-reported diabetes is expected to
be accompanied by an increase in the uptake of pharmaco-
logical treatment, contributing to lower fasting glucose in
treated diabetic patients. The estimates ofmean glucose levels
come from the whole samples, which also include treated di-
abetics, and thus reflect the true trend in population’s risk,
including primary and secondary prevention perspectives.
Numerous studies have found an inverse relation between
the incidence of type 2 diabetes and education, occupation,
and income,47 putting people in lower socio-economic posi-
tions at a particularly high risk. This effect is particularly
worrisome in the current scenario of economic and financial
crisis which Portugal is going through, translated into
increased unemployment, lower purchase power to access
healthy foods anduse of private physical activity facilities, and
a general decrease in the quality of life of the population.48
The study of the trends of diabetes in Portugal contributed
to an updated overview of the burden of diabetes in a South-
ern European country. These data provide information to
p u b l i c h e a l t h 1 2 8 ( 2 0 1 4 ) 2 1 4e2 2 1220support the need of evidence-based policies to implement
effective public health interventions addressing diabetes as
well as its determinants. The reported increase in prevalence
of self-reported diabetes and mean fasting glucose requires
the implementation of effective strategies to promote whole-
population changes in body weight, regular physical activity
and healthy diet as measures to prevent or delay the onset of
type 2 diabetes.Author statements
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